Abstract

PL 04.01 Where We Are Now, and Where We Will Be in 10 years: From North American Perspective

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
FP13.04 KEYNOTE-042 3-Year Survival Update: 1L Pembrolizumab vs Platinum-Based Chemotherapy for PD-L1+ Locally Advanced/Metastatic NSCLC
B.C Cho ... K.K Laktionov
Journal of Thoracic Oncology | VOL. 16
B.C Cho, et. al.B.C Cho ... K.K Laktionov
01 Mar 2021
Changes in PD-L1 tumor proportion score are associated with CD274 gene (encoding PD-L1) copy number variation in non-small cell lung cancer.
Stephanie Leigh Alden ... Mark M Awad
Journal of Clinical Oncology | VOL. 39
Stephanie Leigh Alden, et. al.Stephanie Leigh Alden ... Mark M Awad
20 May 2021
Abstract CT112: AI-powered and manual assessment of PD-L1 are comparable in predicting response to neoadjuvant atezolizumab in patients (pts) with resectable non-squamous, non-small cell lung cancer (NSCLC)
...
American Journal of Cancer | VOL. 82
, et. al. ...
15 Jun 2022
Abstract 3307: Real-world outcomes of first-line pembrolizumab monotherapy for PD-L1-positive (TPS ≥50%) metastatic non-small cell lung cancer (NSCLC)
Vamsidhar Velcheti ... Xin Chen
American Journal of Cancer | VOL. 79
Vamsidhar Velcheti, et. al.Vamsidhar Velcheti ... Xin Chen
01 Jul 2019
View more papers

More From: Journal of Thoracic Oncology

Paper Title
Journal
Date
Author
Analysis of Circulating Tumor DNA Predicts Outcomes of Short-Course Consolidation Immunotherapy in Unresectable Stage III NSCLC
Soyeong Jun ... Maximilian Diehn
Journal of Thoracic Oncology | VOL. -
Soyeong Jun, et. al.Soyeong Jun ... Maximilian Diehn
05 Jul 2024
PP01.95 STK11, KEAP1, and KRAS mutation epidemiology and real-world outcomes in US patients with newly diagnosed metastatic non-small cell lung cancer
Firas Dabbous ... Ferdinandos Skoulidis
Journal of Thoracic Oncology | VOL. 19
Firas Dabbous, et. al.Firas Dabbous ... Ferdinandos Skoulidis
01 Jul 2024
PP01.11 Real-world treatment patterns and outcomes among unresectable Stage III Non-Small Cell Lung Cancer
Ashwini Arunachalam ... Jerome Goldschmidt
Journal of Thoracic Oncology | VOL. 19
Ashwini Arunachalam, et. al.Ashwini Arunachalam ... Jerome Goldschmidt
01 Jul 2024
PP01.133 Clinical and Economic Outcomes Associated with Genomic Testing Strategies in Real-World Data in Advanced Non-Small Cell Lung Cancer (aNSCLC)
Benjamin Levy ... Teddy Saliba
Journal of Thoracic Oncology | VOL. 19
Benjamin Levy, et. al.Benjamin Levy ... Teddy Saliba
01 Jul 2024
View more papers